胸腔镜与开胸手术治疗非小细胞肺癌围手术期相关指标的比较

目的:比较胸腔镜肺癌根治术(VATS)与常规开胸手术治疗非小细胞肺癌(NSCLC)的术中并发症.方法:选取NSCLC患者86例,胸腔镜组和开胸组各43例.比较手术时间、术中出血量、清扫淋巴结组数和个数、疼痛评分、术后第一天引流量、术后下床时间和住院时间等指标.结果:胸腔镜组与开胸组术中出血量[(115.52±22.15) ml vs (205.62±28.21) ml]、痛疼评分[(4.49±1.21) vs (6.24±2.02)]、术后第一天引流量[(320±120.23) ml vs (541±150.91) ml]、下床活动时间[(1.23±0.76) d vs (2.38±0.71) d]及住院时间[(8.28±2.17) d vs (14.31±1.54) d]差异有统计学意义(P<0.05);而手术时间[(145.62±27.26) min vs (142.12±32.41) min]、清扫淋巴结组数[(5.41±1.21) vs (6.02±0.98)]和清扫淋巴结个数[(14.26±2.18) vs (14.58±3.05)]差异无统计学意义(P>0.05);两组患者围术期均无严重并发症.结论:VATS治疗NSCLC具有手术创伤小,患者恢复快,且患者疼痛轻,是NSCLC的选择之一.

Comparison of video-assisted thoracic surgery and conventional thoracotomy on patients with non-small cell lung cancer about perioperative related indexes

Objective:To compare video-assisted thoracic surgery (VATS) and conventional thoracotomy in the treatment of non-small cell lung cancer.Methods:All 86 cases of primary NSCLC specimens were divided into two groups,including the VATS group and the conventional thoracotomy group (43 cases in each group).Compare the difference of operation time,volume of blood loss during operation,groups and numbers of lymphoidectomy,postoperative pain score,postoperative drainage volume of first day,days of first getting out of bed and hospital stay between the two groups.Results:In VATS group,blood loss volume during operation [(115.52±22.15) ml vs (205.62±28.21) ml],postoperative pain score [(4.49±1.21) vs (6.24±2.02)],postoperative drainage volume of first day [(320±120.23) ml vs (541±150.91) ml],days of first getting out of bed [(1.23±0.76) d vs (2.38±0.71) d] and hospital stay [(8.28±2.17) d vs (14.31±1.54) d] were significantly lower than those in CT group (P<0.05).There was no significant difference in operation time [(145.62±27.26) min vs (142.12±32.41) min],groups [(5.41±1.21) vs (6.02±0.98)] and numbers [(14.26±2.18) vs (14.58±3.05)] of lymphoidectomy (P>0.05).Conclusion:VATS in the treatment NSCLC has the advantages of less surgical trauma,rapid recovery,and patients feeling more comfortable and so on,can be used as the first choice for NSCLC patients without surgical treatment.